SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-006522
Filing Date
2024-02-14
Accepted
2024-02-14 14:48:40
Documents
16
Period of Report
2024-02-13
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 52149
2 ex99-1.htm EX-99.1 29154
  Complete submission text file 0001493152-24-006522.txt   311616

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE tcbp-20240213.xsd EX-101.SCH 3962
4 XBRL DEFINITION FILE tcbp-20240213_def.xml EX-101.DEF 26979
5 XBRL LABEL FILE tcbp-20240213_lab.xml EX-101.LAB 37208
6 XBRL PRESENTATION FILE tcbp-20240213_pre.xml EX-101.PRE 25599
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6496
Mailing Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR
Business Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR 01414337557
TC BioPharm (Holdings) plc (Filer) CIK: 0001872812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41231 | Film No.: 24636307
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)